Form 4: DiaMedica Therapeutics Director Exercises Stock Options, Increasing Holdings

Director Randall Michael Giuffre exercised stock options at DiaMedica Therapeutics, increasing his direct and indirect beneficial ownership of voting common shares.

Summary

• On February 13, 2025, Randall Michael Giuffre, a director of DiaMedica Therapeutics Inc., exercised stock options to acquire 12,000 shares at $2.11 and 5,000 shares at $3.65.
• Following these transactions, Giuffre's direct holdings increased to 392,412 voting common shares.
• Giuffre also has indirect ownership of 25,573 shares through 424822 Albert Ltd, where he has sole voting and dispositive power, and 21,070 shares held by his spouse.

Sentiment

Score: 5

Explanation: The sentiment is neutral as it's a standard disclosure of stock option exercises by a company director. It doesn't inherently indicate positive or negative news about the company's performance.

Industry Context

This filing is a routine disclosure of insider transactions, which are common in publicly traded companies. It provides transparency into the actions of company insiders.

Stakeholder Impact

• The transaction may have a minor impact on shareholders due to the increased number of shares outstanding, but the effect is likely minimal given the relatively small number of shares involved.

Key Dates